Exagen Inc. Profile Avatar - Palmy Investing

Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosi…

Medical - Diagnostics & Research
US, Vista [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of XGN's Analysis
CIK: 1274737 CUSIP: 30068X103 ISIN: US30068X1037 LEI: - UEI: -
Secondary Listings
XGN has no secondary listings inside our databases.